Nuace (Darunavir/Ritonavir)
| Active Ingredient | Darunavir/Ritonavir |
|---|---|
| Indication: | HIV infection |
| Manufacturer: | Emcure Pharmaceuticals Ltd. |
| Packaging | 30 Tablets in bottle |
| Strength | 900mg |
| Delivery Time | 6 To 15 days |
Nuace is a combination antiretroviral medication that includes two protease inhibitors: Darunavir and Ritonavir. It is used in the treatment of HIV-1 infection in adults and adolescents. This combination is part of a broader antiretroviral therapy (ART) regimen designed to suppress the HIV virus and improve immune function.
Darunavir works by blocking the HIV protease enzyme, which prevents the virus from multiplying and infecting new cells.
Ritonavir, at a low dose, acts as a booster that increases the effectiveness of Darunavir by slowing its breakdown in the liver.
When taken as prescribed and combined with other antiretroviral drugs, Nuace helps reduce viral load, increase CD4+ cell counts, and delay HIV progression.








There are no reviews yet.